Related Experiment Video
Updated: Jan 27, 2026
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Efficacy and safety of ceftaroline: systematic review and meta-analysis
Maria T Rosanova1, Pedro S Aguilar2, Norma Sberna3
1Hospital J. P. Garrahan, CABA, Buenos Aires, Barragan601 CABA - Argentina -ZIP Code 1408.
Background:
Resistance to antibiotics is steadily increasing. Ceftaroline has a broad spectrum of activity against clinically relevant gram-positive strains including methicillin-resistant Staphylococcus aureus.
Objectives:
This systematic review was conducted to evaluate whether ceftaroline is effective and safe, leading to a lower rate of treatment failures than comparators.
Material And Methods:
Studies were included if they were comparing the efficacy and safety of ceftaroline with other antibiotics.
Data Sources:
Using the search terms 'ceftaroline' or 'ceftaroline fosamil', a search strategy was developed. The efficacy endpoint was the rate of treatment failure, while the safety endpoint was the incidence of adverse events. Heterogeneity bias was estimated using the Q-test, and publication bias was estimated using Egger's test. Null hypothesis was rejected if p value was less than 0.05.
Results:
Only 10 studies were included.
Synthesis Of Results:
The risk of treatment failure was significantly lower for ceftaroline than for comparators, and cumulative meta-analysis showed that the effect size was relevant and precise. Pooled risk ratio was 0.79 (95% confidence interval = 0.65-0.95). The rates of adverse events were similar among the studies, and there were no statistically significant differences between groups. For this endpoint, there was a significant heterogeneity among studies (p = 0.03). Pooled risk ratio for adverse events was 0.98 (95% confidence interval = 0.87-1.10), without a statistical difference.
Discussion:
The risk of treatment failure was significantly lower for ceftaroline than comparators, while the rate of adverse events was similar. To the best of our knowledge, this is the first systematic review on the efficacy and safety of ceftaroline including children and adults. A limitation is that no randomized controlled trials were found in non-complicated skin- and soft-tissue infection and non-community-acquired pneumonia infections; only few cases with methicillin-resistant Staphylococcus aureus isolations and no patients admitted to the intensive care unit were evaluated.
Interpretation:
Ceftaroline may be an option of treatment in complicated skin- and soft-tissue infection and community-acquired pneumonia.
Insights
Ceftaroline significantly reduces treatment failure rates compared to other antibiotics, with similar safety profiles. This systematic review highlights its potential for treating specific infections like MRSA.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Trials
Background:
- Rising antibiotic resistance necessitates evaluating novel therapeutic agents.
- Ceftaroline exhibits broad-spectrum activity, including against methicillin-resistant *Staphylococcus aureus* (MRSA).
Purpose of the Study:
- To systematically review and evaluate the efficacy and safety of ceftaroline.
- To determine if ceftaroline leads to lower treatment failure rates compared to alternative antibiotics.
Main Methods:
- Systematic review including studies comparing ceftaroline with other antibiotics.
- Efficacy endpoint: treatment failure rate; Safety endpoint: incidence of adverse events.
- Statistical analyses included heterogeneity and publication bias assessments.
Main Results:
- Ten studies were included in the meta-analysis.
- Ceftaroline demonstrated a significantly lower risk of treatment failure (pooled risk ratio: 0.79).
- Adverse event rates were comparable between ceftaroline and comparators (pooled risk ratio: 0.98).
Conclusions:
- Ceftaroline is associated with a reduced risk of treatment failure and similar safety compared to other antibiotics.
- This review is the first to include both pediatric and adult populations.
- Ceftaroline shows promise for treating complicated skin and soft-tissue infections and community-acquired pneumonia.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
01:10Review and Preview
Percentiles are a type of fractile that partition data into...
01:13Review and Preview
01:28Survey Safety
01:29Self-Efficacy
01:09Directing Effect of Substituents: meta-Directing Groups
01:20Random and Systematic Errors